what is the dosing schedule for semaglutide & Prescribing Microdosing Semaglutide Chart: A Monthly

Semaglutide, the active ingredient in Ozempic and Wegovy, slows gastric emptying and signals fullness to the brainbut these same mechanisms can trigger digestive changes in some patients

Together, these data indicate that there is a weight-independent component of the glycemic status, which is related to body fat distribution

Comp Biochem Physiol C Toxicol Pharmacol 242:108938

Along with increased physical activity and a reduced-calorie diet, Wegovy is FDA-approved for 2 indications: To reduce excess body weight and for long-term weight maintenance in adults and children age 12 or older with obesity, or in overweight adults with at least one weight-related condition such as heart disease, type 2 diabetes, or high blood pressure